Skip to content
Toggle main navigation
More
Open dropdown to see remaining menu items
Log in
AOA 2025: LNZ100 clinical trial insights from Dr Marc Bloomenstein
Published on July 11, 2025
Marc Bloomenstein, OD, FAAO, is a clinical investigator in the trials and overviews the transformative potential of LNZ100.
Continue reading on website
Other news
Canadian Association of Optometrists Appoints Allison Scott, OD, as Its New President
July 11, 2025
HALIFAX, Nova Scotia—The Canadian Association of Optometrists (CAO) announced at their 39th Biennial Congress held here that it has named Allison Scott, OD, as president for a two-year term. A graduate of the University of Waterloo’s School of Optometry in 2006, Dr. Scott has been a dedicated practitioner in the Halifax region for nearly two decades, the announcement said. Her work spans comprehen
Patterns of Optic Disc Swelling Found as Prognostic Marker in NAION
July 11, 2025
VF defects improved or remained stable in 57% of patients, while the other 42% of patients displayed significant VF deterioration, with a doubling of the absolute number of VF defects. Photo: Neil Miller, MD. Click image to enlarge. Due to its frequency in older adults, nonarteritic anterior ischemic optic neuropathy (NAION) should always be kept in mind by eyecare practitio